focus -WSS

focus

author：focus 2025-10-01 23:06:29 - browse：5

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Nurses recount patients attacks

Wikipedia

WSS

Readout Newsletter: Bluebird, CVS, Contineum

US jobless claims fall again as labor market continues to flash strength

Intermittent fasting comes with a heart risk? Not so fast

Intermittent fasting comes with a heart risk? Not so fast

Future doctors should be trained to promote social change

Methadone treatment changes are coming. Do they go far enough?

hotspot

focus

explore

Virginia high school admissions case could be legal follow

Stanford president’s abrupt resignation sparks debate

FDA approval of Sarepta Duchenne genetic therapy gives me hope

App could help diagnose ear infections more accurately — and at home

Medicare details structure of new drug price negotiation program

Hormonal contraceptives don’t actually treat endometriosis

Hepatitis C has a cure — but many Americans still lack access to it

Telehealth startups are trying to fill the menopause care vacuum

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Nurses recount patients attacks

focus

Sanders wants to replace patents with prizes for drug inventions

Dementia risk linked to living in disadvantaged areas: Study

Physicians and social media: If you see something, say something?

How a Boston hospital is priming medical residents to use GPT

Extensive review finds private equity owners jack up cost of care

Extensive review finds private equity owners jack up cost of care

hotspot

Wikipedia

Wikipedia

Wikipedia